GE HealthCare said Monday it planned to purchase a manufacturer of radioactive substances used in medical imaging procedures for $945 million in cash

The deal expands GE HealthCare’s footprint in radiopharmaceuticals, its fastest-growing segment.

Discover more from RealUS.news

Subscribe now to keep reading and get access to the full archive.

Continue reading